Market Update: Abbott Laboratories (NYSE:ABT) – Mylan Completes Acquisition Of Abbott’s Non-U.S. Developed Markets Specialty And Branded Generics Business

[PR Newswire] – POTTERS BAR, England and PITTSBURGH, Feb. 27, 2015 /PRNewswire/ — Mylan N.V. and Mylan Inc. (MYL) today announced the successful completion of the acquisition of Abbott Laboratories’ (ABT) non-U.S. developed . . . → Read More: Market Update: Abbott Laboratories (NYSE:ABT) – Mylan Completes Acquisition Of Abbott’s Non-U.S. Developed Markets Specialty And Branded Generics Business Similar Articles: Stock Update: The Procter & Gamble Company (NYSE:PG) – P&G shuffles management, aims to fix struggling beauty business Company Update (NYSE:DE): Deere completes acquisition of Auteq Telematica Company Update: Abbott Laboratories (NYSE:ABT) – Abbott Completes Acquisition of CFR Pharmaceuticals; Announces Results of Tender Offer for CFR Shares